Author

Olena Yavorska

University of OxfordORCID 0009-0006-4307-145XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Olena Yavorska2 papers · Genomics England

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:ATAC-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Organism:human· 1 Assay:scRNA-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Alastair SmithiD· 1 shared Anita Krithivas GandhiiD· 1 shared Batchimeg UsukhbayariD· 1 shared Chun‐Xiao SongiD· 1 shared Douglas RA SilveiraiD· 1 shared Lynn Swun QuekiD· 1 shared Marlen MetzneriD· 1 shared Maroof HasaniD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alastair SmithORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintAug 24, 2023

Dysregulation of chromatin via H3K27 methylation underpins differentiation arrest in Isocitrate dehydrogenase-mutant Acute Myeloid Leukaemia.

Douglas RA Silveira, Prodromos Chatzikyriakou, Pilar Casares Aláez…·Lynn Swun Quek

This study shows that IDH2 mutations in AML block differentiation by altering H3K27 methylation, and that Enasidenib can reverse this block by modulating chromatin states.

DOI 10.1101/2023.08.24.554641

𝕏 PostBluesky